| __timestamp | Regeneron Pharmaceuticals, Inc. | Veracyte, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 504755000 | 40786000 |
| Thursday, January 1, 2015 | 838526000 | 47876000 |
| Friday, January 1, 2016 | 1177697000 | 52035000 |
| Sunday, January 1, 2017 | 1320433000 | 55348000 |
| Monday, January 1, 2018 | 1556200000 | 65276000 |
| Tuesday, January 1, 2019 | 1834800000 | 82720000 |
| Wednesday, January 1, 2020 | 1346000000 | 89118000 |
| Friday, January 1, 2021 | 1824900000 | 181193000 |
| Saturday, January 1, 2022 | 2115900000 | 174078000 |
| Sunday, January 1, 2023 | 2631300000 | 184232000 |
| Monday, January 1, 2024 | 2954400000 |
Unveiling the hidden dimensions of data
In the competitive world of biotechnology, managing operational expenses is crucial for sustained growth. This analysis compares the Selling, General, and Administrative (SG&A) expenses of Regeneron Pharmaceuticals, Inc. and Veracyte, Inc. from 2014 to 2023. Over this period, Regeneron has seen a staggering 421% increase in SG&A expenses, peaking at $2.63 billion in 2023. In contrast, Veracyte's SG&A expenses grew by 352%, reaching $184 million in the same year.
Regeneron's substantial investment in SG&A reflects its aggressive expansion strategy, while Veracyte's more modest increase suggests a focus on lean operations. This divergence highlights the different paths companies can take in scaling their operations. As the biotech industry continues to evolve, understanding these financial strategies provides valuable insights into corporate growth and efficiency.
Selling, General, and Administrative Costs: Gilead Sciences, Inc. vs Regeneron Pharmaceuticals, Inc.
Operational Costs Compared: SG&A Analysis of Vertex Pharmaceuticals Incorporated and Regeneron Pharmaceuticals, Inc.
Breaking Down SG&A Expenses: Regeneron Pharmaceuticals, Inc. vs Takeda Pharmaceutical Company Limited
Regeneron Pharmaceuticals, Inc. or Opthea Limited: Who Manages SG&A Costs Better?
Regeneron Pharmaceuticals, Inc. vs Jazz Pharmaceuticals plc: SG&A Expense Trends
Selling, General, and Administrative Costs: Regeneron Pharmaceuticals, Inc. vs Soleno Therapeutics, Inc.
Alnylam Pharmaceuticals, Inc. or Veracyte, Inc.: Who Manages SG&A Costs Better?
Sarepta Therapeutics, Inc. vs Veracyte, Inc.: SG&A Expense Trends
SG&A Efficiency Analysis: Comparing TG Therapeutics, Inc. and Veracyte, Inc.
Amneal Pharmaceuticals, Inc. or Veracyte, Inc.: Who Manages SG&A Costs Better?
Veracyte, Inc. vs Merus N.V.: SG&A Expense Trends
SG&A Efficiency Analysis: Comparing Veracyte, Inc. and ACADIA Pharmaceuticals Inc.